Seagen
SGEN
#585
Rank
C$60.49 B
Marketcap
C$320.62
Share price
-0.07%
Change (1 day)
71.77%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -C$1.07 Billion

According to Seagen 's latest financial reports the company's current earnings are C$2.30 Billion. In 2022 the company made an earning of -C$0.86 Billion, an increase over its 2021 earnings that were of -C$0.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$1.07 Billion23.97%
2022 -C$0.86 Billion-10.13%
2021 -C$0.96 Billion-214.28%
2020 C$0.83 B-370.63%
2019 -C$0.31 Billion-15.17%
2018 -C$0.37 Billion32.79%
2017 -C$0.28 Billion37.19%
2016 -C$0.21 Billion18%
2015 -C$0.17 Billion56.34%
2014 -C$0.11 Billion23.07%
2013 -C$88.12 Million
2011 -C$0.21 Billion111.72%
2010 -C$95.6 Million-19.63%
2009 -C$0.12 Billion-7.55%
2008 -C$0.13 Billion64.95%
2007 -C$78 Million38.4%
2006 -C$56.36 Million25.36%
2005 -C$44.96 Million-14.86%
2004 -C$52.8 Million61.92%
2003 -C$32.61 Million-7.67%
2002 -C$35.32 Million6.76%
2001 -C$33.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.84 B-1,439.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$8.37 B-855.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.27 B-305.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.45 B-1,313.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$14.03 B-1,366.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-C$86.74 Million-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-C$88 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.44 Billion-60.91%๐Ÿ‡บ๐Ÿ‡ธ USA